CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)

Détails

ID Serval
serval:BIB_613A30FECF6C
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)
Périodique
Blood
Auteur(s)
Helbling  D., Mueller  B. U., Timchenko  N. A., Schardt  J., Eyer  M., Betts  D. R., Jotterand  M., Meyer-Monard  S., Fey  M. F., Pabst  T.
ISSN
0006-4971 (Print)
Statut éditorial
Publié
Date de publication
08/2005
Volume
106
Numéro
4
Pages
1369-75
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Aug 15
Résumé
The pericentric inversion of chromosome 16, inv(16)(p13q22), is associated with acute myeloid leukemia (AML) subtype M4Eo that is characterized by the presence of myelomonocytic blasts and atypical eosinophils. This rearrangement fuses the CBFB and MYH11 genes, with the latter encoding the smooth muscle myosin heavy chain (SMMHC). The myeloid transcription factor CCAAT/enhancer-binding protein alpha (CEBPA) is crucial for normal granulopoiesis. Alterations of structure and expression of CEBPA have been implicated in particular subtypes of AML. Here, we found that conditional expression of core-binding factor beta (CBFB)-SMMHC in U937 cells suppresses CEBPA protein expression and binding activity. However, CEBPA mRNA levels remained unchanged. No differences were detected in CEBPA mRNA levels in patients with inv(16) AML-M4Eo (n = 12) compared to patients with AML with a normal karyotype and M4 subtype (n = 6), whereas CEBPA protein and binding activity were significantly reduced in patients with CBFB-SMMHC. Furthermore, calreticulin, an inhibitor of CEBPA translation, was induced on mRNA and protein level in CBFB-SMMHC patients with AML and after expression of CBFB-SMMHC in the U937-cell system. Inhibition of calreticulin by siRNA restored CEBPA levels. Our results suggest that modulation of CEBPA by calreticulin represents a novel mechanism involved in the differentiation block in CBFB-SMMHC AML.
Mots-clé
Acute Disease Adult Aged CCAAT-Enhancer-Binding Protein-alpha/*genetics/metabolism Calreticulin/antagonists & inhibitors/*genetics/physiology Cell Differentiation Female Humans Leukemia, Myeloid/*genetics/pathology Male Middle Aged Oncogene Proteins, Fusion/*genetics RNA, Neoplasm/analysis RNA, Small Interfering/pharmacology Translocation, Genetic
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/01/2008 15:18
Dernière modification de la notice
20/08/2019 15:18
Données d'usage